Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan 16;13(1):220.
doi: 10.3390/biomedicines13010220.

Inflammatory Biomarkers and Lipid Parameters May Predict an Increased Risk for Atrial Arrhythmias in Patients with Systemic Sclerosis

Affiliations

Inflammatory Biomarkers and Lipid Parameters May Predict an Increased Risk for Atrial Arrhythmias in Patients with Systemic Sclerosis

Veronika Sebestyén et al. Biomedicines. .

Abstract

Background/objectives: Autoimmune inflammation enhances the electrical instability of the atrial myocardium in patients with systemic sclerosis (SSc); thus, atrial arrhythmia risk is increased, which might be predicted by evaluating the P wave interval and dispersion of a 12-lead surface electrocardiogram (ECG).

Methods: We examined 26 SSc patients and 36 healthy controls and measured the P wave interval and P wave dispersion of the 12-lead surface ECG in each patient. Furthermore, echocardiography and 24-h Holter ECG were performed and levels of inflammatory laboratory parameters, including serum progranulin (PGRN), sVCAM-1, sICAM-1, leptin and C-reactive protein (CRP), were determined. Lipid parameters, such as Apo A-I, LDL-cholesterol (LDL-C), oxidized LDL (oxLDL) and the LDL and HDL subfractions were also evaluated.

Results: The P wave interval showed a significant positive correlation with the levels of Apo A-I, LDL-C, CRP, sVCAM-1, sICAM-1 and leptin. The oxLDL level correlated positively with P wave dispersion. Of note, significant positive correlation was also found between the large HDL percentage and the P wave interval.

Conclusions: Our results suggest that PGRN, sVCAM-1, sICAM-1, leptin, CRP, LDL-C and oxLDL, along with LDL and HDL subfractions, might have a role in atrial arrhythmogenesis in patients with SSc.

Keywords: LDL and HDL subfractions; atrial arrhythmias; electrocardiography; inflammation; leptin; oxLDL; systemic sclerosis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

Figures

Figure 1
Figure 1
(AC): Pairwise comparisons of atrial arrhythmia risk markers between the control and SSc groups. (D,E): Echocardiographic parameters describing the size of the left atrium in the control and SSc groups. LA: left atrium, P int: P wave interval, P max: maximal P wave interval, Pd: P wave dispersion. * p < 0.05; ** p < 0.01; **** p < 0.0001; n.s.: not significant.
Figure 2
Figure 2
Correlations of the atrial arrhythmia risk markers with the different examined parameters in SSc patients. (A): Correlation between the CRP and P wave interval. (B,C): Correlations between the levels of adhesion molecules and P wave interval. (DF): Correlations of different lipid parameters and adipokines with the atrial arrhythmia risk markers. CRP: C-reactive protein, sICAM-1: soluble ICAM-1, sVCAM-1: soluble VCAM-1, Apo A-I: apolipoprotein A-1, LDL-C: low-density lipoprotein cholesterol, oxLDL: oxidized low-density lipoprotein, P int: P wave interval, P max: maximal P wave interval, Pd: P wave dispersion. * p < 0.05; ** p < 0.01; *** p < 0.001.
Figure 3
Figure 3
(A): The P wave interval correlated negatively with the small HDL percentage. (B): The P wave interval showed a positive correlation with the large HDL percentage. (C): The Apo A-I level was found to be positively correlated with the P wave interval. HDL: high-density lipoprotein, P int: P wave interval, Apo A-I: apolipoprotein A-I, * p < 0.05; ** p < 0.01.

Similar articles

References

    1. Geyer M., Muller-Ladner U. The pathogenesis of systemic sclerosis revisited. Clin. Rev. Allergy Immunol. 2011;40:92–103. doi: 10.1007/s12016-009-8193-3. - DOI - PubMed
    1. Peoples C., Medsger T.A., Jr., Lucas M., Rosario B.L., Feghali-Bostwick C.A. Gender differences in systemic sclerosis: Relationship to clinical features, serologic status and outcomes. J. Scleroderma Relat. Disord. 2016;1:177–240. doi: 10.5301/jsrd.5000209. - DOI - PMC - PubMed
    1. Tzelepis G.E., Kelekis N.L., Plastiras S.C., Mitseas P., Economopoulos N., Kampolis C., Gialafos E.J., Moyssakis I., Moutsopoulos H.M. Pattern and distribution of myocardial fibrosis in systemic sclerosis: A delayed enhanced magnetic resonance imaging study. Arthritis Rheum. 2007;56:3827–3836. doi: 10.1002/art.22971. - DOI - PubMed
    1. Bruni C., Buch M.H., Furst D.E., De Luca G., Djokovic A., Dumitru R.B., Giollo A., Polovina M., Steelandt A., Bratis K., et al. Primary systemic sclerosis heart involvement: A systematic literature review and preliminary data-driven, consensus-based WSF/HFA definition. J. Scleroderma Relat. Disord. 2022;7:24–32. doi: 10.1177/23971983211053246. - DOI - PMC - PubMed
    1. Gawalko M., Balsam P., Lodzinski P., Grabowski M., Krzowski B., Opolski G., Kosiuk J. Cardiac Arrhythmias in Autoimmune Diseases. Circ. J. 2020;84:685–694. doi: 10.1253/circj.CJ-19-0705. - DOI - PubMed

LinkOut - more resources